Ezekowitz Alan

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ezekowitz Alan's trades of Fulcrum Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
417.59
Quantity 91,941
Value US$551,199
US Septerna Inc (SEPN)
Transaction date
Purchase
Price
164.93
Quantity 23,787 +25.0%
Value US$4,004,411
US Septerna Inc (SEPN)
Transaction date
Purchase
Price
6.00
Quantity 41,355 +65.9%
Value US$248,130
US Septerna Inc (SEPN)
Transaction date
Purchase
Price
5.82
Quantity 37,835 +151.9%
Value US$220,260
US Septerna Inc (SEPN)
Transaction date
Purchase
Price
6.35
Quantity 7,491 +43.0%
Value US$47,544
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-26
PlS Planned sale
78,277 +18.3%
364.33
US$208,165 		78,277 +18.3% 364.33 US$208,165
2026-06-26 2026-06-26
PrS Proposed sale
91,941
417.59
US$551,199 		91,941 417.59 US$551,199
2025-03-10 2025-03-07
US Septerna Inc (SEPN)
B Purchase
23,787 +25.0%
164.93
US$4,004,411 		23,787 +25.0% 164.93 US$4,004,411
2025-03-06 2025-03-06
US Septerna Inc (SEPN)
B Purchase
41,355 +65.9%
6.00
US$248,130 		41,355 +65.9% 6.00 US$248,130
2025-03-06 2025-03-05
US Septerna Inc (SEPN)
B Purchase
37,835 +151.9%
5.82
US$220,260 		37,835 +151.9% 5.82 US$220,260
2025-03-06 2025-03-04
US Septerna Inc (SEPN)
B Purchase
7,491 +43.0%
6.35
US$47,544 		7,491 +43.0% 6.35 US$47,544